Solutions and Services | Pharmaco-Vigilance & Safety
Literature Screening
Contact us now to receive further information and an assessment from our experts. We will work with you to evaluate the best approach for your business processes.
Pharmacovillance
Literature Screening in pharmacovigilance is a critical process that involves the systematic review of scientific and medical literature to identify individual case safety reports (ICSRs) and any new information that could impact the safety and efficacy of medicinal products.
This process is essential for Marketing Authorisation Holders (MAHs) in the European Economic Area (EEA) to remain compliant with EU legal requirements and to ensure the ongoing safety monitoring of their medicines.
At Arithmos, we offer a comprehensive Literature Screening service that leverages AI-validated platforms to monitor both international and local scientific literature.
Our state-of-the-art scientific literature monitoring platform enhances the efficiency of reporting and simplifies the Medical Literature Monitoring process.
Our Literature Screening service provides you with the following advantages:
- Comprehensive Research: Simultaneous searches across multiple databases of high relevance, including PubMed, Crossref, Dialnet, Directory of Open Access Journals, and SciFLO.
- Speed and Precision: Quick and automated searches by keywords, ensuring that no relevant article is missed.
- Duplicate Exclusion: Automatic removal of duplicate search results, streamlining the review process.
- Regulatory Compliance: Adherence to GxP and FDA 21 CFR Part 11, ensuring that your literature screening meets all regulatory standards.
- Volume Management: Capability to handle high volumes of scientific articles, making it suitable for MAHs with extensive portfolios.
Get an assessment
Let’s work together to address the challenges in pharmacovigilance and ensure the safety of patients worldwide. Contact us to explore how our services can solve your pharmacovigilance needs.